West Paces Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07K Buy
+52
New +$4.2K ﹤0.01% 482
2025
Q2
Sell
-10
Closed -$899 415
2025
Q1
$899 Hold
10
﹤0.01% 499
2024
Q4
$799 Hold
10
﹤0.01% 501
2024
Q3
$900 Hold
10
﹤0.01% 480
2024
Q2
$787 Hold
10
﹤0.01% 508
2024
Q1
$872 Sell
10
-519
-98% -$44.3K ﹤0.01% 513
2023
Q4
$43.6K Sell
529
-3,959
-88% -$302K 0.01% 238
2023
Q3
$352K Sell
4,488
-1,086
-19% -$90.9K 0.11% 92
2023
Q2
$491K Sell
5,574
-1,136
-17% -$97.8K 0.14% 78
2023
Q1
$541K Sell
6,710
-466
-6% -$38K 0.17% 76
2022
Q4
$558K Buy
7,176
+89
+1% +$7.21K 0.18% 77
2022
Q3
$572K Buy
7,087
+61
+0.9% +$5.48K 0.2% 72
2022
Q2
$631K Sell
7,026
-3
-0% -$304 0.21% 68
2022
Q1
$780K Buy
7,029
+403
+6% +$42.6K 0.24% 65
2021
Q4
$685K Sell
6,626
-64
-1% -$7.41K 0.21% 68
2021
Q3
$839K Buy
6,690
+57
+0.9% +$7.38K 0.29% 56
2021
Q2
$823K Sell
6,633
-323
-5% -$40.6K 0.3% 55
2021
Q1
$822K Buy
6,956
+107
+2% +$12.5K 0.33% 57
2020
Q4
$802K Buy
6,849
+23
+0.3% +$2.53K 0.36% 56
2020
Q3
$709K Buy
6,826
+260
+4% +$26.1K 0.36% 58
2020
Q2
$602K Sell
6,566
-64
-1% -$6.14K 0.33% 63
2020
Q1
$598K Sell
6,630
-798
-11% -$84.9K 0.38% 52
2019
Q4
$843K Sell
7,428
-171
-2% -$18.8K 0.46% 47
2019
Q3
$825K Hold
7,599
0.49% 46
2019
Q2
$740K Sell
7,599
-234
-3% -$21.4K 0.46% 46
2019
Q1
$713K Buy
7,833
+137
+2% +$12.3K 0.5% 44
2018
Q4
$700K Sell
7,696
-52
-0.7% -$4.86K 0.54% 48
2018
Q3
$762K Sell
7,748
-83
-1% -$7.67K 0.55% 43
2018
Q2
$670K Buy
7,831
+60
+0.8% +$5.01K 0.5% 51
2018
Q1
$623K Buy
7,771
+1,055
+16% +$87K 0.46% 50
2017
Q4
$542K Sell
6,716
-112
-2% -$8.97K 0.4% 63
2017
Q3
$531K Sell
6,828
-836
-11% -$69.4K 0.4% 56
2017
Q2
$680K Buy
7,664
+1,705
+29% +$144K 0.54% 41
2017
Q1
$480K Buy
5,959
+786
+15% +$61.4K 0.38% 62
2016
Q4
$368K Buy
+5,173
New +$406K 0.34% 72

Other funds holding MDT

West Paces Advisors's MDT Position: Q2 2026 in Review

West Paces Advisors opened a new position in Medtronic (MDT) in Q2 2026: 52 shares worth $4.07K. The stake represents ﹤0.01% of the portfolio and ranks #482 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in MDT as recently as Q1 2025.

West Paces Advisors first reported a position in MDT in Q4 2016 and has held it in 35 quarters since. The position peaked at $843K in Q4 2019. 546 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • West Paces Advisors held 52 shares of Medtronic worth $4.07K as of Q2 2026.
  • Medtronic was a new West Paces Advisors position in Q2 2026.
  • Medtronic made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #482 holding.
  • West Paces Advisors first reported a position in Medtronic in Q4 2016 and has held it in 35 quarters since.
  • West Paces Advisors's Medtronic position peaked at $843K in Q4 2019.
  • 546 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.